Evidence map›Paper›PMID 39776636›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2025

Synthesis, crystal structure and Hirshfeld surface analysis of bis-(acetyl-acetonato-κ

Kyzlarkhan Siddikova, Daminbek Ziyatov, Akmaljon Tojiboev, Jamshid Ashurov, Zukhra Kadirova, Shahlo Daminova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Synthesis, crystal structure, Hirshfeld surface and DFT analysis of bis-(4-oxo-4-phenyl-but-2-en-2-olato-κActa crystallographica. Section E, Crystallographic communications · 2026
    Article
  2. Synthesis, crystal structure and Hirshfeld surface analysis of (2-amino-benzo-thia-zole-κActa crystallographica. Section E, Crystallographic communications · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kyzlarkhan SiddikovaKarshi Engineering Economics Institute, Mustakillik Avenue 225, Karshi 180100, Uzbekistan.
Daminbek ZiyatovNational University of Uzbekistan named after Mirzo Ulugbek University Street 4 Tashkent 100174 Uzbekistan.
Akmaljon TojiboevUniversity of Geological Sciences, Olimlar Street 64, Tashkent 100125, Uzbekistan.ORCID https://orcid.org/0000-0001-8061-0914
Jamshid AshurovInstitute of Bioorganic Chemistry, Academy of Sciences of Uzbekistan, Mirzo Ulugbek Street 83, Tashkent 100125, Uzbekistan.ORCID https://orcid.org/0000-0002-4441-2803
Zukhra KadirovaUzbek-Japan Innovation Center of Youth, University Street 2B, Tashkent 100095, Uzbekistan.
Shahlo DaminovaNational University of Uzbekistan named after Mirzo Ulugbek University Street 4 Tashkent 100174 Uzbekistan.ORCID https://orcid.org/0000-0003-2606-3221

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The title compound, [Cu(C

Indexed as

acetyl­acetonebenzimidazolecopper complexcrystal structureHirshfeld surface analysis

Identifiers

PMID39776636
PMCPMC11701777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.